Citation Impact
Citing Papers
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Therapeutic Leukapheresis in Hyperleukocytic Leukaemias—The Experience of a Tertiary Institution in Singapore
2005
Maintenance of the Hematopoietic Stem Cell Pool by CXCL12-CXCR4 Chemokine Signaling in Bone Marrow Stromal Cell Niches
2006 Standout
Features of the dendritic cell lineage
2010 StandoutNobel
Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis
2007
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
HIV gag protein is efficiently cross‐presented when targeted with an antibody towards the DEC‐205 receptor in Flt3 ligand‐mobilized murine DC
2009 StandoutNobel
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
2001
Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature
2008
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation
2011
Chronic graft-versus-host disease
2003 Standout
Skeletal remodeling in health and disease
2007 Standout
Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis
2004
Some interfaces of dendritic cell biology
2003 StandoutNobel
A simple controlled‐rate freezing method without a rate‐controlled programmed freezer provides optimal conditions for both large‐scale and small‐scale cryopreservation of umbilical cord blood cells
2003 StandoutNobel
Graft-versus-host disease
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias
2016
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis
2014
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
2010 StandoutNature
Allogeneic transplantation of blood stem cells: Coming of age?
2001
Treatment of Relapsed/Refractory Multiple Myeloma
2009
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhage
2007
Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia
2011
Cytokines and hematopoietic stem cell mobilization
2006
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Hyperleukocytosis, leukostasis and leukapheresis: Practice management
2012
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
2005
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis
2014
Hyperleukocytosis and leukostasis: management of a medical emergency
2016
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS
2004
Acute Myeloid Leukemia
2015 Standout
Reversal of Leukostasis-Related Pulmonary Distress Syndrome After Leukapheresis and Low-Dose Chemotherapy in Acute Myeloid Leukemia
2011
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation
2002
Hyperleucocytosis in paediatric acute myeloid leukaemia – the challenge of white blood cell counts above 200 × 109/l. The NOPHO experience 1984–2014
2017
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
2001
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation
2009
Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis – a retrospective study from a tertiary center
2017
Fludarabine in the treatment of chronic lymphocytic leukemia: a review
2009
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity
2000
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
2003
Cancer treatment and survivorship statistics, 2016
2016 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo
2000
Cancer treatment and survivorship statistics, 2019
2019 Standout
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility
2001
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
2002
Rapid Engraftment Without Significant Graft-Versus-Host Disease After Allogeneic Transplantation of CD34+ Selected Cells From Peripheral Blood
1997
Multiple Myeloma
2011 Standout
Acute myeloid leukaemia
2016
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
2000
Hematological Problems in Pediatric Intensive Care
2013 Standout
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
2014
Works of P Anderlini being referenced
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development
2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma
2002
Leukapheresis Reduces Early Mortality in Patients with Acute Myeloid Leukemia with High White Cell Counts But Does Not Improve Long Term Survival
2001
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease
2000
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease
1995
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease
1995